CD163 and liver cancer: We detected the expression of CYPJ, CD86 (a marker for M1 TAMs), CD163 (a marker for M2 TAMs), CD8 (a marker for CD8+ T cell), and EpCAM (a marker for tumor cells) in tissues from liver cancer patients using the mIHC method.